drugset / Trial / NCT03826550
Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
Phase 3
Completed
655 enrolled
Encube Ethicals Pvt. Ltd.
Novum Pharmaceutical Research Services · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Therapeutic Equivalence of Diclofenac Sodium Gel 3% and Solaraze ®, in the treatment of Actinic Keratosis
Timeline
- Start
- 2018-01-12
- Primary completion
- 2018-06-30
- Completion
- 2018-07-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diclofenac | Other / unclassified | 3 % | Topical |